Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 7457

2.

Continuous Inhalation of Ipratropium Bromide for Acute Asthma Refractory to β2-agonist Treatment.

Koumbourlis AC, Mastropietro C.

J Pediatr Pharmacol Ther. 2015 Jan-Feb;20(1):66-9. doi: 10.5863/1551-6776-20.1.66.

3.

High-Dose Inhaled Salbutamol Does Not Improve 10-km Cycling Time-Trial Performance.

Koch S, Ahn JR, Koehle MS.

Med Sci Sports Exerc. 2015 Apr 8. [Epub ahead of print]

PMID:
25856682
4.

IL-13 desensitizes β<sub>2</sub>-adrenergic receptors in human airway epithelial cells through a 15-lipoxygenase/G protein receptor kinase 2 mechanism.

Albano GD, Zhao J, Etling EB, Park SY, Hu H, Trudeau JB, Profita M, Wenzel SE.

J Allergy Clin Immunol. 2015 Mar 24. pii: S0091-6749(15)00226-2. doi: 10.1016/j.jaci.2015.02.006. [Epub ahead of print]

PMID:
25819984
5.

ASM-024, a Piperazinium Compound, Promotes the In Vitro Relaxation of β2-Adrenoreceptor Desensitized Tracheas.

Israël-Assayag E, Beaulieu MJ, Cormier Y.

PLoS One. 2015 Mar 23;10(3):e0120095. doi: 10.1371/journal.pone.0120095. eCollection 2015.

6.

Salmeterol Efficacy and Bias in the Activation and Kinase-Mediated Desensitization of β2-Adrenergic Receptors.

Gimenez LE, Baameur F, Vayttaden SJ, Clark RB.

Mol Pharmacol. 2015 Jun;87(6):954-964. Epub 2015 Mar 17.

PMID:
25784721
7.

Beta-2 Adrenergic Agonists Are Substrates and Inhibitors of Human Organic Cation Transporter 1.

Salomon JJ, Hagos Y, Petzke S, Kühne A, Gausterer JC, Hosoya KI, Ehrhardt C.

Mol Pharm. 2015 Mar 18. [Epub ahead of print]

PMID:
25751092
9.

Volatile anesthetics for status asthmaticus in pediatric patients: a comprehensive review and case series.

Carrié S, Anderson TA.

Paediatr Anaesth. 2015 May;25(5):460-7. doi: 10.1111/pan.12577. Epub 2015 Jan 8.

PMID:
25580870
10.

Identification of high affinity bioactive Salbutamol conformer directed against mutated (Thr164Ile) beta 2 adrenergic receptor.

Bandaru S, Tiwari G, Akka J, Marri VK, Alvala M, Gutlapalli VR, Nayarisseri A, Mundluru HP.

Curr Top Med Chem. 2015;15(1):50-6.

PMID:
25579570
11.

Clinical outcomes after bilevel positive airway pressure treatment for acute asthma exacerbations.

Golden C, Xu M, Estrada CM, Arnold DH.

JAMA Pediatr. 2015 Feb;169(2):186-8. doi: 10.1001/jamapediatrics.2014.2767. No abstract available.

PMID:
25546456
12.

The expanding role of aerosols in systemic drug delivery, gene therapy and vaccination: an update.

Laube BL.

Transl Respir Med. 2014 Jan 13;2:3. doi: 10.1186/2213-0802-2-3. eCollection 2014. Review.

13.

Molecular insights into the dynamics of pharmacogenetically important N-terminal variants of the human β2-adrenergic receptor.

Shahane G, Parsania C, Sengupta D, Joshi M.

PLoS Comput Biol. 2014 Dec 11;10(12):e1004006. doi: 10.1371/journal.pcbi.1004006. eCollection 2014 Dec.

14.

Asthma: pathogenesis and novel drugs for treatment.

Olin JT, Wechsler ME.

BMJ. 2014 Nov 24;349:g5517. doi: 10.1136/bmj.g5517. Review.

15.

[Rapid effectiveness and better medication compliance].

Gessner C.

MMW Fortschr Med. 2014 Oct 9;156(17):67. German. No abstract available.

PMID:
25417481
16.

A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized study.

Singh D, Pujol H, Ribera A, Seoane B, Massana E, Astbury C, Ruiz S, de Miquel G.

BMC Pulm Med. 2014 Nov 14;14:176. doi: 10.1186/1471-2466-14-176.

17.

Development and characterization of pepducins as Gs-biased allosteric agonists.

Carr R 3rd, Du Y, Quoyer J, Panettieri RA Jr, Janz JM, Bouvier M, Kobilka BK, Benovic JL.

J Biol Chem. 2014 Dec 26;289(52):35668-84. doi: 10.1074/jbc.M114.618819. Epub 2014 Nov 13.

PMID:
25395624
18.

β2 adrenergic agonist attenuates house dust mite-induced allergic airway inflammation through dendritic cells.

Kato G, Takahashi K, Tashiro H, Kurata K, Shirai H, Kimura S, Hayashi S.

BMC Immunol. 2014 Oct 30;15(1):39.

19.

Clinical utility and development of the fluticasone/formoterol combination formulation (Flutiform(®)) for the treatment of asthma.

Tan RA, Corren J.

Drug Des Devel Ther. 2014 Sep 30;8:1555-61. doi: 10.2147/DDDT.S36556. eCollection 2014.

20.

Superiority of combined phosphodiesterase PDE3/PDE4 inhibition over PDE4 inhibition alone on glucocorticoid- and long-acting β2-adrenoceptor agonist-induced gene expression in human airway epithelial cells.

BinMahfouz H, Borthakur B, Yan D, George T, Giembycz MA, Newton R.

Mol Pharmacol. 2015 Jan;87(1):64-76. doi: 10.1124/mol.114.093393. Epub 2014 Oct 16.

PMID:
25324049
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk